Get the Stockscreener App
0.00
100.00%
-15.68
Reshape Lifesciences Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
See More
Previous Close:
$15.68
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.35M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
0.00
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$519.00
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Compare RSLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
0.00 | 9.35M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.86 | 223.39B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.95 | 136.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.69 | 135.88B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.72 | 126.37B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.32 | 48.39B | 5.88B | 1.34B | 799.60M | 2.3489 |
Reshape Lifesciences Inc Stock (RSLS) Latest News
Global Medical Tourism Market to Reach USD 58 Billion by 2032, Due to Shift Toward Affordable, Quality Healthcare Abroad | DelveInsight - Business Upturn
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
HIND Stock Price and Chart — NASDAQ:HIND - TradingView
Is ReShape Lifesciences Inc. stock a smart buy before Fed meetingEarnings Miss & Safe Swing Trade Setups - Newser
Will ReShape Lifesciences Inc. stock recover faster than peersBear Alert & Community Trade Idea Sharing - Newser
Is ReShape Lifesciences Inc. stock dividend yield sustainableWeekly Investment Summary & AI Optimized Trading Strategy Guides - Newser
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Vyome Holdings Inc. Reports Post-Merger Financials - MSN
Why ReShape Lifesciences Inc. stock is rated strong buyDay Trade & Smart Allocation Stock Tips - newser.com
Will ReShape Lifesciences Inc. stock maintain dividend yieldJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
How ReShape Lifesciences Inc. stock performs in rising dollar environmentMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Live market analysis of ReShape Lifesciences Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Tools to monitor ReShape Lifesciences Inc. recovery probability2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Comparing ReShape Lifesciences Inc. in custom built stock radarsTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
Is now a turning point for ReShape Lifesciences Inc.Profit Target & Stepwise Entry/Exit Trade Alerts - newser.com
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - MSN
Will ReShape Lifesciences Inc. stock benefit from green energy trendsTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Why ReShape Lifesciences Inc. stock is a must watch in 2025July 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Is ReShape Lifesciences Inc. stock safe for conservative investorsPortfolio Return Summary & Weekly Momentum Picks - newser.com
Head-To-Head Analysis: ReShape Lifesciences (OTCMKTS:RSLSD) versus Bioventus (NASDAQ:BVS) - Defense World
United States Weight Loss Devices Market 2025: Top - openPR.com
Will earnings trigger a reversal in ReShape Lifesciences Inc.2025 Growth vs Value & Long-Term Growth Plans - newser.com
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):